Anti-CGRP and Anti-CGRP Receptor Monoclonal Antibodies for Migraine Prophylaxis: Retrospective Observational Study on 209 Patients.

Vittorio SchweigerPaola BellamoliFrancesco TausLeonardo GottinAlvise MartiniMarta NizzeroEleonora BonoraGiovanna Del BalzoKatia DonadelloErica SecchettinGabriele FincoDaniele De SantisEnrico Polati

Published in: Journal of clinical medicine (2024)

this retrospective study comes out in favor of both significant efficacy and safety of anti-CGRP and anti-CGRP receptors mAbs in migraine patients. Further methodologically stronger studies are necessary to validate our observation.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
patient reported outcomes